Variant report
Variant | nsv889179 |
---|---|
Chromosome Location | chr7:125700894-125724789 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:125717773..125720293-chr7:125877157..125879096,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs571875508 | chr7:125712641-125712642 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs111291297 | chr7:125712679-125712680 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs719319 | chr7:125712737-125712738 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs540247729 | chr7:125712738-125712739 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs719320 | chr7:125712783-125712784 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
6 | rs60902712 | chr7:125712802-125712803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs529359303 | chr7:125712804-125712805 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs189961460 | chr7:125712808-125712809 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs562697292 | chr7:125712809-125712810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs574607905 | chr7:125712837-125712838 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs578064754 | chr7:125712877-125712878 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs533469432 | chr7:125712929-125712930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs113655649 | chr7:125712936-125712937 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs76358927 | chr7:125712953-125712954 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs534645232 | chr7:125713041-125713042 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs546278839 | chr7:125713082-125713083 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs181181633 | chr7:125713083-125713084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs78658019 | chr7:125713085-125713086 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs557193955 | chr7:125713101-125713102 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs186143503 | chr7:125713176-125713177 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs540384170 | chr7:125713195-125713196 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs185241571 | chr7:125716801-125716802 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs543193403 | chr7:125716847-125716848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs10272238 | chr7:125716866-125716867 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs529381048 | chr7:125716872-125716873 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs145617619 | chr7:125716886-125716887 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs79727721 | chr7:125716916-125716917 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs116783624 | chr7:125716951-125716952 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs189568378 | chr7:125716955-125716956 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs373031710 | chr7:125716992-125716993 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs570142927 | chr7:125716998-125716999 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs148889923 | chr7:125717008-125717009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs7784474 | chr7:125717020-125717021 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs142607248 | chr7:125717035-125717036 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs535273095 | chr7:125717086-125717087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs556086737 | chr7:125717087-125717088 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs151277708 | chr7:125717184-125717185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs187015327 | chr7:125717807-125717808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs536702047 | chr7:125717865-125717866 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs145923677 | chr7:125717867-125717868 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs374188353 | chr7:125717895-125717896 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs1582263 | chr7:125717910-125717911 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs146705718 | chr7:125717913-125717914 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs1582264 | chr7:125717914-125717915 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
45 | rs138932684 | chr7:125717952-125717953 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs3038737 | chr7:125717968-125717969 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs386411217 | chr7:125717969-125717970 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs386411218 | chr7:125717970-125717971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs397836037 | chr7:125717971-125717972 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs534298779 | chr7:125718003-125718004 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 23792589 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Non-small cell lung cancer | 19889201 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Autism | 18414403 | CNVD |
Autism | 19401682 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Melanoma | 19188590 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21509527 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Epilepsy | 21635232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Autism | 20808228 | CNVD |
Autism | 19246517 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:125712600-125713200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr7:125716800-125717000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
3 | chr7:125717000-125717200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
4 | chr7:125717800-125724200 | Weak transcription | H9 Cell Line | embryonic stem cell |
5 | chr7:125719000-125719400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr7:125719000-125719600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
7 | chr7:125719000-125719800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr7:125719000-125720000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
9 | chr7:125719200-125719400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
10 | chr7:125719200-125720200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
11 | chr7:125719400-125719600 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
12 | chr7:125719400-125724400 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
13 | chr7:125719400-125731800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
14 | chr7:125719600-125724600 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
15 | chr7:125719600-125726000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
16 | chr7:125724200-125724800 | Strong transcription | H9 Cell Line | embryonic stem cell |
17 | chr7:125724400-125725600 | ZNF genes & repeats | HUES6 Cell Line | embryonic stem cell |
18 | chr7:125724600-125726200 | ZNF genes & repeats | ES-WA7 Cell Line | embryonic stem cell |